Antihypertensive and antioxidant potential of vanillic acid, a phenolic compound in L-NAME-induced hypertensive rats: A dose-dependence study

Redox Report

Volumn 16, Issue 5, 2011, Pages 208-215

  Kumar, Subramanian ^a   Prahalathan, Pichavaram ^a   Raja, Boobalan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Antioxidant; Hypertension; L NAME; Vanillic acid

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ASCORBIC ACID; GLUTATHIONE; LIPID HYDROPEROXIDE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRITE; THIOBARBITURIC ACID; VANILLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; HISTOPATHOLOGY; HYPERTENSION; KIDNEY FUNCTION; LIPID PEROXIDATION; LIVER FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; TOXICITY TESTING;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; HYPERTENSION; MALE; NG-NITROARGININE METHYL ESTER; RATS; RATS, WISTAR; VANILLIC ACID;

RATTUS; RATTUS NORVEGICUS;

EID: 80053925680     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000211Y.0000000009     Document Type: Article

References (42)

1. Yusuf S, Ounpuu S, Anand A. Global burden of cardiovascular diseases: part 1 general considerations, the epidemiologic transition, risk factors and impact of urbanization. Circulation 2001;104:2746-53.
2. Silva-Herdade A, Saldanha C. Hemorheological effects of valsartan in L-NAME induced hypertension in rats. Open Circul Vasc J 2011;4:1-5.
3. Gerald W, Dryden Ion D, Gavin A, Craig J. McClain clinical implications of oxidative stress and antioxidant therapy. Cur Gastroenterol Rep 2005;7:308-16.
4. Maxwell SR. Prospects for the use of antioxidant therapies. Drugs 1995;49:345-61.
5. Getz GS, Reardon CA. Nutrition and cardiovascular disease. Arterioscler Thromb Vasc Biol 2007;27:2499-506.
6. Retelny VS, Neuendorf A, Roth JL. Nutrition protocols for the prevention of cardiovascular disease. Nutr Clin Pract 2008;23: 468-76.
7. Civolani C, Barghini P, Roncetti AR, Ruzzi M, Schiesser A. Bioconversion of ferulic acid into vanillic acid by means of a vanillate-negative mutant of Pseudomonas fluorescens strain BF13. Appl Environ Microbiol 2000;66:2311-17.
8. Duke JA. Handbook of phytochemical constituents of GRAS herbs and other economic plants. Boca Raton: CRC Press; 1992.
9. Varma RS, Shukla A, Chatterjee RK. Evaluation of vanillic acid analogues as a new class of antifilarial agents. Indian J Exp Biol 1993;31:819-21.
10. Rai RP, Maurya MS. Synthesis and evaluation of antibacterial activity of vanillin derivatives. J Sci Tech 1966;4:275-6.
11. Delaquis P, Stanich K, Toivonen P. Effect of pH on the inhibition of Listeria spp. by vanillin and vanillic acid. J Food Protec 2005;68:1472-6.
12. Stanely Mainzen Prince P, Dhanasekar K, Rajakumar S. Preventive effects of Vanillic acid on lipids, Bax, Bcl-2 and myocardial infarct size on isoproterenol-induced myocardial infarcted rats: a biochemical and in vitro study. Cardiovasc Toxicol 2011;11:58-66.
13. Tsuda H, Uehara N, Iwahori Y, Asamoto M, Ligo M, Nagao M, et al. Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo [4, 5] quinolone in the rat. Japanese J Cancer Res 1994;85:1214-9.
14. Raja B, Deepa Mol S. The protective role of vanillic acid against acetaminophen induced hepatotoxicity in rats. J Pharm Res 2010;3:1480-4.
15. Afkir S, Benoit Nguelefack T, Aziz M, Zoheir J, Cuisinaud G, Bnouham M, et al. Arbutus unedo prevents cardiovascular and morphological alterations in L-NAME-induced hypertensive rats Part I: cardiovascular and renal hemodynamic effects of Arbutus unedo in L-NAME-induced hypertensive rats. J Ethnopharmacol 2008;116:288-95.
16. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrite and nitrate in biological fluids. Anal Biochem 1982;126:131-8.
17. Niehaus WG, Samuelson B. Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Pharmacol 1968;6:126-30.
18. Jiang ZY, Hunt JV, Wolff SP. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 1992;202:384-9.
19. Rao KS, Recknagel RO. Early onset of lipid peroxidation in rat liver after carbon tetrachloride administration. Exp Mol Pathol 1968;9:271-8.
20. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys 1984;21:130-2.
21. Sinha KA. Colorimetric assay of catalase. Anal Biochem 1972; 47:389-94.
22. Rotruck JT, Pop AL, Ganther H, Hafeman BG, Hoeksira WG. Selenium: biochemical role as a component of glutathione peroxides. Science 1973;179:588-90.
23. Baker H, Frank O, De Angelis B, Feingold S. Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol. Nutr Rep Int 1980;21:531-6.
24. Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys 1959;82:70-7.
25. Katsumi H, Nishikawa M, Hashida H. Development of nitric oxide donors for the treatment of cardiovascular diseases. Cardiovasc Hematol Agents Med Chem 2007;5:204-8.
26. Ribeiro MO, Antunes E, De Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthase, a new model of arterial hypertension. Hypertension 1992;20:298-303.
27. Jover B, Herizi A, Ventre F, Dupont M, Mimran A. Sodium and angiotension in hypertension induced by long-term nitric oxide blockade. Hypertension 1993;21:944-8.
28. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992;90:278-81.
29. Ulker S, McKeown PP, Bayraktutan U. Vitamins Reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 2003;41: 534-9.
30. Fridovich I. The biology of oxygen radicals. Science 1978;201: 875-80.
31. Frank L, Massaro D. Oxygen toxicity. Am J Med 1980;69: 117-26.
32. Kumar S, Saravana Kumar M, Raja B. Efficacy of piperine, an alkaloidal constituent of pepper on nitric oxide, antioxidants and lipid peroxidation markers in L-NAME induced hypertensive rats. Int J Res Pharm Sci 2010;3:300-7.
33. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 2005;57:715-24.
34. Hamberg M, Svensson J, Wakabayashi T, Samuelsson B. Isolation and structure of two prostaglandins endoperoxides that cause platelet aggregation. Proc Natl Acad Sci 1974;71: 345-59.
35. Roy AKD, Gordon MJ, Campbell FM, Duthie GG, James WPT. Vitamin-E requirement, transport and metabolism: role of α-tocopherol-binding protein. J Nutr Biochem 1994;5: 562-70.
36. Karthikeyan J, Rani P. Enzymatic and non enzymatic antioxidants in selected piper speice. Ind J Exp Biol 2003;41: 135-40.
37. Abidi P, Afaq F, Arif JM, Lohani M, Rahman Q. Chrysotilemediated imbalance in the glutathione redox system in the development of pulmonary injury. Toxicol Lett 1999; 106:31-9.
38. Dey A, Cederbaum AI. Alcohol and oxidative liver injury. Hepatology 2006;43:63-74.
39. Hoetzel A, Welle A, Schmidt R, Loop T, Humar M, Ryter SW, et al. Nitric oxide-deficiency regulates hepatic heme oxygenase-1. Nitric Oxide Biol Chem 2008;18:61-9.
40. Loria P, Lonardo A, Carulli L, Verrone AM, Ricchi M, Lombardini S, et al. The metabolic syndrome and nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2005;22: 31-6.
41. Bech JN, Nielsen CB, Ivarsen P, Jensen KT, Pedersen EB. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans. Am Physiol 1998; 274:914-23.
42. Burtis CA, Ashwood ER. Enzymes, Teitz fundamentals of clinical chemistry. 4th ed. Philadelphia, USA: NB Saunders Company; 1996. p. 312-35.